Success Stories
Roy, Medullablastoma, cancer-free since 2002Jodi, Anaplastic Astrocytoma, cancer-free since 2004
Tori, Brainstem glioma, cancer-free for 2003
(left to right) Click for more patient stories
To establish a personalized treatment plan we first must identify the expression (activity) of patient's oncogenes. The gene expression is identified through the oncogene testing (genetic markers testing). The identification of oncogenes enables our medical team to assess patient's response chance and to determine the most optimal combination of medications.
In some cases conventional therapy is the most appropriate treatment for a patient. Our Clinic offers customized combination therapies consisting of conventional therapy and other approved targeted therapies to maximize effectiveness while minimizing the side effects that typically occur when using the traditional therapies alone.
Surgery, radiation therapy, and specialized imaging such as MRI, CT and PET scan, are provided at other local medical facilities.
Gene-targeted medications are drugs that selectively block the growth and spread of cancer without affecting the healthy cells. Targeted therapies interfere with cancer cell growth differently than cytotoxic chemotherapy and at various points during the development, growth, and spread of cancer. By switching off the signals that make cancer cells grow and divide uncontrollably, targeted cancer therapies can help stop the growth of cancer cells.
Targeted medications have shown to be tolerated easier than standard chemotherapy and radiation with no side effects or minimal adverse reactions noted.
There are currently close to 30 targeted therapeutics approved by the FDA (as of January 2011). This number grows rapidly with the advancement of the research in genomics. All of the FDA approved gene-targeted medications are available for treatment at the Burzynski Clinic. The combination of targeted medications is customized for each patient and determined by the type of oncogenes involved in patient's cancer (Personalized Treatment).
Our Clinic provides an experimental therapy based on Antineoplastons which are peptide and amino acid derivatives discovered by Dr. Burzynski, M.D., Ph.D.
Antineoplastons are multi-targeted therapy that effects approximately 100 genes involved in cancer.
The Antineoplaston therapy is a subject of FDA supervised clinical trials. Currently, only patients eligible to enroll into a clinical trial may receive such treatment.
We believe the quality of the treatment is determined not only by the effectiveness of the cancer therapy but also by the quality of the patient's life during and after the treatment.
Burzynski Clinic provides a wide range of services to assure the comfort, convenience and well being of our patients, including 24-hour monitoring, rehabilitation, dietary supplements and nutrition counseling.
We take pride in offering the highest quality of personalized patient care. Each patient receives personal attention of a medical team assigned to them, consisting of a monitoring nurse, research associate and senior physician caring for the patient during the entire treatment.
Our supervision continues after the patient returns home and resumes care under their local physician until the treatment is completed.
Support Clinical Trials and Research:
In this video, 4-year-old Tori Moreno's father shares his story about his daughter's recovery from an inoperable brainstem tumor.
Copyright © 2006-2011 by Burzynski Clinic

